TRxADE HEALTH (NASDAQ:MEDS) operates a web-based pharmaceutical marketplace designed to streamline drug procurement for independent pharmacies, healthcare providers and long-term care facilities across the United States. Through its proprietary platform, the company enables registered pharmacies to source FDA‐approved branded and generic medications directly from wholesalers and manufacturers, improving inventory management and cost efficiency. The marketplace incorporates real-time pricing, order tracking and digital invoicing, allowing clients to compare offers and secure competitive rates in a single interface.
In addition to its B2B marketplace, TRxADE Health offers patient‐facing services under the MEDS™ brand. These include telehealth consultations, online prescription transfers and fulfillment through licensed pharmacy partners. Members gain access to discounted pricing on a broad range of medications, including specialty and chronic care therapies, while benefiting from home delivery or in‐store pickup options. The integrated model aims to enhance adherence, lower out-of-pocket expenses and expand access to prescribed treatments.
The company was founded in 2011 and is headquartered in Neptune, New Jersey. TRxADE Health completed its initial public offering in 2017 and trades on the NASDAQ under the ticker symbol MEDS. Since its inception, the firm has grown its network to include hundreds of pharmacy locations and dozens of wholesale partners, serving customers in all fifty states. Over time, the company has pursued strategic alliances to expand its service offerings and explore opportunities in adjacent markets, such as pharmacy benefit management and digital health solutions.
Under the leadership of Chairman and CEO Sudarshan Khanna, TRxADE Health’s management team brings decades of experience in healthcare technology, pharmacy operations and regulatory compliance. The company’s board features industry veterans with backgrounds in pharmaceutical distribution, health IT and finance. Together, they continue to refine the platform’s capabilities, pursue strategic growth initiatives and enhance value for both pharmacy clients and members of the consumer-facing network.
